Literature DB >> 1750795

Raynaud's phenomenon: its relevance to scleroderma.

J J Belch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1750795      PMCID： PMC1033318          DOI： 10.1136/ard.50.suppl_4.839

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  48 in total

1.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

2.  Vascular damage and factor-VIII-related antigen in the rheumatic diseases.

Authors:  J J Belch; A A Zoma; I M Richards; K McLaughlin; C D Forbes; R D Sturrock
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

Review 3.  Late-onset Raynaud's syndrome: diagnostic and therapeutic considerations.

Authors:  E I Friedman; L M Taylor; J M Porter
Journal:  Geriatrics       Date:  1988-12

Review 4.  Raynaud's phenomenon and disease.

Authors:  M B Cardelli; D M Kleinsmith
Journal:  Med Clin North Am       Date:  1989-09       Impact factor: 5.456

5.  Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.

Authors:  M Rademaker; E D Cooke; N E Almond; J A Beacham; R E Smith; T G Mant; J D Kirby
Journal:  BMJ       Date:  1989-03-04

6.  Cutaneous hypoxia in patients with systemic sclerosis (scleroderma).

Authors:  J L Silverstein; V D Steen; T A Medsger; V Falanga
Journal:  Arch Dermatol       Date:  1988-09

7.  Survival in scleroderma.

Authors:  R Bennett; R Bluestone; P J Holt; E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

8.  Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.

Authors:  J R Seibold; J N Harris
Journal:  J Rheumatol       Date:  1985-02       Impact factor: 4.666

9.  Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.

Authors:  R A DiGiacomo; J M Kremer; D M Shah
Journal:  Am J Med       Date:  1989-02       Impact factor: 4.965

10.  Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.

Authors:  D A Yardumian; D A Isenberg; M Rustin; G Belcher; M L Snaith; P M Dowd; S J Machin
Journal:  Br J Rheumatol       Date:  1988-06
View more
  11 in total

1.  [Systemic sclerosis].

Authors:  S Kleinert; H P Tony; C Kneitz
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

Review 2.  The patient experience of Raynaud's phenomenon in systemic sclerosis.

Authors:  John D Pauling; Lesley Ann Saketkoo; Marco Matucci-Cerinic; Francesca Ingegnoli; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2019-01-01       Impact factor: 7.580

3.  Large vessel disease in CREST.

Authors:  J J Belch; D J Veale; T Colleridge
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

4.  Lipid peroxidation and trace elements in systemic sclerosis.

Authors:  Mohammed Tikly; Kalavati Channa; Penny Theodorou; Mairam Gulumian
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

5.  The association of Raynaud's syndrome with rheumatoid arthritis--a meta-analysis.

Authors:  Peter Hartmann; Melvin Mohokum; Peter Schlattmann
Journal:  Clin Rheumatol       Date:  2011-04-02       Impact factor: 2.980

Review 6.  International consensus criteria for the diagnosis of Raynaud's phenomenon.

Authors:  Emanual Maverakis; Forum Patel; Daniel G Kronenberg; Lorinda Chung; David Fiorentino; Yannick Allanore; Serena Guiducci; Roger Hesselstrand; Laura K Hummers; Chris Duong; Bashar Kahaleh; Alexander Macgregor; Marco Matucci-Cerinic; Frank A Wollheim; Maureen D Mayes; M Eric Gershwin
Journal:  J Autoimmun       Date:  2014-02-01       Impact factor: 7.094

7.  Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens.

Authors:  H Imai; M J Fritzler; R Neri; S Bombardieri; E M Tan; E K Chan
Journal:  Mol Biol Rep       Date:  1994-03       Impact factor: 2.316

8.  Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome.

Authors:  Lukas Andreas Heger; Mark Kerber; Marcus Hortmann; Samuel Robinson; Maximilian Mauler; Daniela Stallmann; Daniel Duerschmied; Christoph Bode; Christoph Hehrlein; Ingo Ahrens
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

9.  Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.

Authors:  D J Veale; T A Collidge; J J Belch
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

10.  Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion.

Authors:  Nila H Servaas; Barbara Mariotti; Maarten van der Kroef; Catharina G K Wichers; Aridaman Pandit; Flavia Bazzoni; Timothy R D J Radstake; Marzia Rossato
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.